ALK and cancer: The results showed that VH20-OKT3-Fc mobilized the T cell killing of ALK-positive IMR-32 and SH-SY5Y cells with IC50s of 0.1 nM and 0.15 nM, respectively, while without killing of ALKnegative SK-N-AS cancer cell.